FrancophonIA/ELRC3.0 huggingface dataset:
English: Cattle Sheep Chickens Pigs
Slovenian: 100 mg/g prašek govedo prašiči kokoši
English: Enroxyl Max
Slovenian: Enroxyl Max govedo subkutano
English: Cattle Goats Rabbits Sheep Fish Pigs Poultry
Slovenian: 500 mg prašek za peroralno raztopino govedo koze kunci ovce ribe prašiči perutnina
English: Pigs Lambs Cattle Hens Turkeys
Slovenian: Enrogal peroralna raztopina prašiči govedo jagnjeta koze jagnjeta perutnina
English: Belgium Dopharma Research BV Zalmweg 24
Slovenian: Nizozemska Dopharma Research BV Zalmweg 24
English: Enroxil 10% , enrofloksacyna 100mg/ml solution for injection for cattle and pig
Slovenian: Enroxil 10% , enrofloksacyna 100mg/ml solution for injection for cattle and pig enrofloksacin 10 g/100 ml govedo prašiči intramuskular no, subkutano
English: Belgium Bayer N.V. Louizalaan 143
Slovenian: Islandija Bayer A/S Nørgaardsvej 32
English: ADVOCIN 180, 180 mg/ml, solução injectável para bovinos
Slovenian: ADVOCIN 180, 180 mg/ml, solução injectável para bovinos danofloksacin 180 mg/ml govedo subkutano, intravensko
English: Enrofloxacin 10 g/100 ml
Slovenian: Enrofloxacino Universal enrofloksacin 10 g/100 ml peroralna raztopina perutnina kunci
English: Enrofloxacin 10%
Slovenian: Baytril enrofloksacin 10 %
English: Inoxyl Bolus
Slovenian: Inoxyl Bolus oksolinska kislina
English: Enroxil solution for injection 50 mg/ml for calves, pigs and dogs
Slovenian: Enroxil solution for injection 50 mg/ml for calves, pigs and dogs govedo prašiči psi subkutano, intramuskular no
English: Enrofloxacin 0.5%
Slovenian: enrofloksacin 0,5 % peroralna raztopina pujski
English: Baytril Injection 5% Enrofloxacin 5 g/100 ml
Slovenian: BAYTRIL 0,5% Sol. Orale enrofloksacin 0,5 g/100 ml peroralna raztopina pujski
English: Calves Lambs Poultry
Slovenian: Quimiocoli peroralna raztopina pitovni piščanci
English: Enroxil 5% premix pro medikaci krmiva
Slovenian: Enroxil 5% premix enrofloksacin 50 mg/g predmešanica za pripravo zdravilne krmne mešanice perutnina prašiči
English: Baytril 0,5 % Oral Solution
Slovenian: Baytril 0,5 % Oral Solution peroralna raztopina prašiči
English: Calves Pigs Poultry
Slovenian: peroralna raztopina piščanci purani
English: Marbofloxacin 100 mg
Slovenian: Marboken marbofloksacin 100 mg govedo intramuskular no
English: Syvaquinol 100 injectable
Slovenian: Syvaquinol 100 injectable govedo prašiči subkutano, intramuskular no
English: 1MUI/g Colistin sulphate 200mg/g oxolinic acid
Slovenian: 1 Mi.e./g kolistin sulfata 200 mg/g oksolinske kisline prašek za peroralno raztopino teleta pujski pitovni piščanci
English: Cattle Sheep Chickens Hens
Slovenian: peroralna raztopina pitovni piščanci plemenske kokoši purani
English: Powerflox 100 mg/ml Solution for Injection for Cattle and Pigs
Slovenian: Powerflox 100 mg/ml Solution for injection govedo prašiči intravensko, intramuskular no, subkutano
English: Marbofloxacin 20 mg/ml
Slovenian: marbofloksacin 20 mg/ml govedo prašiči intravensko
English: Advocin 180, 180 mg/ml, Solution for Injection for Cattle
Slovenian: ADVOCIN 180, 180 mg/ml, Solution for Injection for Cattle danofloksacin 180 mg/ml govedo subkutano, intravensko
English: ADVOCIN 180, 180 mg/ml, Solution for Injection for Cattle
Slovenian: Advocin 180, 180 mg/ml, Solution for Injection for Cattle danofloksacin 180 mg/ml govedo subkutano, intravensko
English: Flumiquil 50 % Flumequine
Slovenian: Flumiquil 50% flumekvin
English: Flumiquil 50% Flumequine
Slovenian: Flumiquil 50 % flumekvin
English: Quinoflox 100 mg/ml oral solution
Slovenian: Quinoflox 100 mg/ml oral solution peroralna raztopina piščanci purani
English: Syvaquinol 25 Inyectable
Slovenian: Syvaquinol 25 Inyectable govedo prašiči psi subkutano, intramuskular no
English: Enrofloksacyna 10% enrofloksacyna 100 mg/ml oral solution for chicken, turkey and pogeons
Slovenian: Enrofloksacyna 10% enrofloksacyna 100 mg/ml oral solution for chicken, turkey and pogeons enrofloksacin 10 g/100 ml peroralna raztopina piščanci purani golobi
English: Cattle Lambs Pigs
Slovenian: govedo prašiči intramuskular no
English: Cat
Slovenian: Kent
English: Industrial Area Aradippou 7100; P.O.
Slovenian: Industrial Area Aradippou 7100; P.O. Box 40261 6302 Larnaca
English: Intraruminal device Cattle
Slovenian: govedo intramuskular no
English: Flumesyva Liquido
Slovenian: Flubactin flumekvin
English: Medicated premix Pigs Poultry
Slovenian: 50 g predmešanica za pripravo zdravilne krmne mešanice govedo prašiči perutnina kunci
English: Baytril 10 % injection Enrofloxacin 100 mg/ml
Slovenian: Baytril 10 % injection enrofloksacin 100 mg/ml govedo prašiči subkutano, intramuskular no
English: Marbokem 100 mg/ml solution for injection
Slovenian: MARBOKEM 100 mg/ml solution for injection marbofloksacin 100 mg/ml govedo intramuskular no
English: BAYTRIL 5% solução injectável
Slovenian: BAYTRIL 5% solução injectável govedo prašiči subkutano
English: Cattle (non ruminating) Hens (non laying)
Slovenian: 500 mg/g prašek govedo (neprežvekovalci) kokoši (nenesnice)
English: Danofloxacin 25 mg/ml
Slovenian: 25 mg/ml danofloksacina)
English: Enrobioflox 5% injection, 50mg/ml solution for injection for pig, cattle and dog
Slovenian: Enrobioflox 5% injection, 50mg/ml solution for injection for pig, cattle and dog enrofloksacin 10 g/100 ml govedo prašiči psi intramuskular no, subkutano
English: Injektionslösung 100 mg/ml für Rinder und Schweine
Slovenian: Injektionslösung 100 mg/ml für Rinder und Schweine govedo prašiči subkutano, intramuskular no
English: Lithuania Laboratorios Hipra, S.A. Avda.
Slovenian: Bolgarija Laboratorios Hipra, S.A. Avda.
English: Enrofloxacin 5% WDT, Solution for injection
Slovenian: Enrofloxacin 5% WDT, Solution for injection govedo prašiči psi intramuskular no, subkutano
English: 500 mg/g
Slovenian: 500 mg/g prašek prašiči
English: Baytril 10% Solucion Inyectable
Slovenian: Baytril 10% Solucion Inyectable govedo prašiči subkutano, intramuskular no
English: BAYTRIL 0,5% solução oral
Slovenian: BAYTRIL 0,5% solução oral peroralna raztopina prašiči
English: Colistine sulphate 12 g Oxolinic acid 100g
Slovenian: kolistin sulfat oksolinska kislina kolistin sulfat 12 g oksolinska kislina 100 g predmešanica za pripravo zdravilne krmne mešanice prašiči ovce ptice
English: Chickens Pigeons Turkeys
Slovenian: Roxacin peroralna raztopina perutnina
English: Advocin 2.5% Solution for Injection
Slovenian: Advocin 2.5% Solution for Injection danofloksacin 2,5 % raztopina za injiciranje govedo prašiči subkutano, intramuskular no
English: Intramuscular, subcutaneous, intramuscular
Slovenian: govedo svinje subkutano, intramuskular no
English: Baytril 5 % injection Enrofloxacin 50 mg/ml
Slovenian: Baytril Bolus enrofloksacin 500 mg bolus teleta
English: Ref. EMEA/690893/2008
Slovenian: EMEA/86067/2009
English: The Committee also had concerns over what happens to the medicine in the body, how it should be given and how safe it is.
Slovenian: Nadalje je Odbor je izrazil zaskrbljenost glede tega, kaj se z zdravilom zgodi v telesu, kako bi ga bilo treba dajati in kako varno je.
English: International non-proprietary name (INN): contusugene ladenovec
Slovenian: Mednarodno nelastniško ime (INN): contusugene ladenovec
English: People who have this mutation are more likely to develop cancer.
Slovenian: Pri ljudeh s to mutacijo je razvoj raka verjetnejši.
English: Li-Fraumeni cancer can occur in many areas of the body but usually affects the breast, brain, bone or soft tissue (tissue that connects, surrounds and supports other structures in the body).
Slovenian: Li-Fraumeni rak se lahko razvije skoraj kjer koli v telesu, vendar navadno prizadene prsi, možgane, kosti ali mehko tkivo (tkivo, ki povezuje, obdaja ali podpira druge strukture v telesu).
English: Advexin was designated as an orphan medicinal product on 23 October 2006.
Slovenian: Zdravilo Advexin je bilo 23. oktobra 2006 določeno kot zdravilo sirota.
English: The company also presented the results of a number of small studies looking at the effects of a range of doses of Advexin on different types of cancer.
Slovenian: Družba je predstavila tudi rezultate številnih manjših študij, ki so proučevale učinke različnih odmerkov zdravila Advexin na različne vrste raka.
English: This is a type of virus that has been altered genetically so that it can carry a gene into the cells of the body.
Slovenian: To je vrsta virusa, ki je bila gensko spremenjena tako, da lahko nese gen v celice telesa.
English: Questions and answers on the withdrawal of the marketing application for Advexin
Slovenian: Vprašanja in odgovori v zvezi z umikom vloge za dovoljenje za promet z zdravilom Advexin
English: The effects of Advexin were first tested in experimental models before being studied in humans.
Slovenian: Učinki zdravila Advexin so bili najprej preskušeni na poskusnih modelih, nato pa so jih raziskali pri ljudeh.
English: The patient received 12 Advexin injections into some of the tumours over a five-month period.
Slovenian: Bolnik je v obdobju petih mesecev prejel 12 injekcij zdravila Advexin v nekatere tumorje.
English: Advexin was expected to be used to treat Li-Fraumeni cancer in patients from the age of 18 years.
Slovenian: Zdravilo Advexin naj bi se uporabljalo za zdravljenje Li-Fraumeni raka pri bolnikih, starejših od 18 let.
English: On 17 December 2008, Gendux Molecular Limited officially notified the Committee for Medicinal Products for Human Use (CHMP) that it wishes to withdraw its application for a marketing authorisation for Advexin for the treatment of Li-Fraumeni cancer.
Slovenian: Družba Gendux Molecular Limited je dne 17. decembra 2008 obvestila Odbor za zdravila za uporabo v humani medicini (CHMP), da želi umakniti vlogo za dovoljenje za promet z zdravilom Advexin, namenjenim za zdravljenje Li-Fraumeni raka.
English: The application was at day 179 when the company withdrew.
Slovenian: Družba je vlogo umaknila na 179. dan postopka.
English: The company presented information from a study on one patient with Li-Fraumeni cancer in the lower abdomen, the bones and the brain.
Slovenian: Družba je predstavila podatke iz študije na enem bolniku z Li-Fraumeni rakom v spodnjem delu trebuha, kosteh in možganih.
English: What are the consequences of the withdrawal for patients undergoing clinical trials or compassionate use programmes with Advexin?
Slovenian: Kakšne so posledice umika za bolnike, ki sodelujejo v kliničnih preskušanjih ali programih sočutne uporabe zdravila Advexin?
English: The effectiveness of the medicine was assessed by using scans to look at how the tumours responded to treatment.
Slovenian: Za ocenjevanje učinkovitosti zdravila so uporabili slikanje, ki je pokazalo, kako so se tumorji odzvali na zdravljenje.
English: Based on the review of the data and the company's response to the CHMP list of questions, at the time of the withdrawal, the CHMP had some concerns and was of the provisional opinion that Advexin could not have been approved for the treatment of Li-Fraumeni cancer.
Slovenian: Na podlagi pregleda podatkov in odgovorov družbe na seznam vprašanj, ki jih je do umika vloge zastavil CHMP , je imel Odbor zadržke in je začasno menil, da zdravila Advexin ni mogoče odobriti za zdravljenje Li-Fraumeni raka.
English: What is Advexin?
Slovenian: Kaj je zdravilo Advexin?
English: The CHMP was concerned that there was not enough evidence to show that the injection of Advexin into Li-Fraumeni tumours led to benefits for patients.
Slovenian: CHMP je skrbelo, da ni dovolj dokazov, ki bi potrjevali, da je injiciranje zdravila Advexin v tumorje Li-Fraumeni za bolnike koristno.
English: London, 22 January 2009 Doc.
Slovenian: London, 22.01.09 Sklic na dok.
English: The virus in Advexin is an ‘adenovirus' that has been engineered so that it cannot make copies of itself and therefore does not cause infections in humans.
Slovenian: Virus, uporabljen pri zdravilu Advexin, je „adenovirus“, ki je bil gensko spremenjen tako, da se ne more podvajati in posledično pri ljudeh ne more povzročiti okužbe.
English: What was Advexin expected to be used for?
Slovenian: Za kaj naj bi se zdravilo Advexin uporabljalo?
English: In addition, the company had not supplied enough evidence to demonstrate that Advexin could be made in a reliable manner, or that it would not be harmful to the environment or to people in close contact with the patient.
Slovenian: Družba tudi ni predložila dovolj dokazil o zanesljivi izdelavi zdravila Advexin ali o njegovi neškodljivosti za okolje ali ljudi, ki bi z njim rokovali.
English: Li-Fraumeni cancer is a type of cancer that occurs in patients with Li-Fraumeni syndrome, a condition where a gene called p53 is defective because of a mutation.
Slovenian: Li-Fraumeni rak je vrsta raka, ki se pojavi pri bolnikih s Li-Fraumeni sindromom, stanjem, pri katerem je gen, imenovan p53, poškodovan zaradi mutacije.
English: Because cancer cells contain damaged DNA, the p53 protein either helps to repair the DNA or causes the cells to die.
Slovenian: Ker rakave celice vsebujejo poškodovano DNK, protein p53 pomaga pri popravilu DNK ali pa povzroči odmrtje celice.
English: Advexin was expected to be injected directly into the tumours, thus allowing the cancer cells to produce normal p53 protein again.
Slovenian: Zdravilo Advexin naj bi se injiciralo neposredno v tumor in tako omogočilo rakavim celim, da ponovno proizvedejo normalen protein p53.
English: The gene carried by the virus in Advexin is the normal (non-defective) p53 gene.
Slovenian: Gen, ki ga nosi virus v zdravilu Advexin, je normalen (nepoškodovan) gen p53.
English: The p53 protein, which is produced from the non-defective p53 gene present in the human body, normally contributes to the repair of damaged DNA and causes cell death when the DNA cannot be repaired.
Slovenian: Protein p53, ki ga proizvaja v telesu prisoten nepoškodovani gen p53, običajno pomaga pri obnovi poškodovane DNK in povzroči smrt celic, če DNK ne more biti popravljena.
English: The active substance in Advexin, contusugene ladenovec, is a ‘viral vector'.
Slovenian: Zdravilna učinkovina v zdravilu Advexin, contusugene ladenovec, je virusni vektor.
English: The company did not inform the CHMP whether there were any consequences of the withdrawal for patients in clinical trials or compassionate use programmes with Advexin.
Slovenian: Družba odbora CHMP ni obvestila, ali ima umik kakršne koli posledice za bolnike v kliničnih preskušanjih ali programih sočutne uporabe zdravila Advexin.
English: In Li-Fraumeni cancer, where the p53 gene is defective, the p53 protein does not work properly and the cancer cells can continue to grow and divide.
Slovenian: Pri Li-Fraumeni raku, kjer je gen p53 poškodovan, protein p53 ne deluje pravilno in zato rakave celice lahko rastejo in se delijo.
English: Advexin is a suspension for injection that contains contusugene ladenovec, a genetically modified virus which carries the p53 gene.
Slovenian: Zdravilo Advexin je suspenzija za injiciranje, ki vsebuje contusugene ladenovec, gensko spremenjeni virus, ki nosi gen p53.
English: How is Advexin expected to work?
Slovenian: Kako naj bi zdravilo Advexin delovalo?
English: Advexin was expected to cure or slow down the disease by restoring the normal protective function of the cells.
Slovenian: Pričakovano je bilo, da bo zdravilo Advexin ponovno vzpostavilo normalno zaščitno funkcijo celic in tako ozdravilo ali upočasnilo bolezen.
English: Further information on Kymriah can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Nadaljnje informacije o zdravilu Kymriah so na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The European Medicines Agency therefore decided that Kymriah's benefits are greater than its risks and it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zato zaključila, da so koristi zdravila Kymriah večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: What measures are being taken to ensure the safe and effective use of Kymriah?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Kymriah?
English: These results were comparable to those from studies of patients receiving standard cancer treatments.
Slovenian: Ti izidi so bili primerljivi z izidi iz študij z bolniki, ki so prejemali standardna zdravila za zdravljenje raka.
English: Kymriah is a medicine for treating two types of blood cancer:
Slovenian: Kymriah je zdravilo za zdravljenje dveh vrst krvnega raka:
English: Other information about Kymriah
Slovenian: Druge informacije o zdravilu Kymriah
English: Patients should be closely monitored for 10 days after treatment for side effects and are advised to stay close to a specialist hospital for at least 4 weeks after treatment.
Slovenian: Bolnike je treba deset dni po zdravljenju skrbno spremljati glede pojava neželenih učinkov in jim priporočiti, da ostanejo blizu specialistične bolnišnice še vsaj štiri tedne po zdravljenju.
English: What benefits of Kymriah have been shown in studies?
Slovenian: Kakšne koristi zdravila Kymriah so se pokazale v študijah?
English: As for all medicines, data on the use of Kymriah are continuously monitored.
Slovenian: Tako kot za vsako zdravilo se tudi podatki o uporabi zdravila Kymriah stalno spremljajo.
English: Serious side effects occur in most patients.
Slovenian: Pri večini bolnikov se pojavijo resni neželeni učinki.
English: Why is Kymriah authorised in the EU?
Slovenian: Zakaj je bilo zdravilo Kymriah odobreno v EU?
English: What are the risks associated with Kymriah?
Slovenian: Kakšna tveganja so povezana z zdravilom Kymriah?
English: This is a type of medicine that works by delivering genes into the body.
Slovenian: Gre za skupino zdravil, ki delujejo tako, da prenesejo gene v telo.
English: What is Kymriah and what is it used for?
Slovenian: Kaj je zdravilo Kymriah in za kaj se uporablja?
English: An overview of Kymriah and why it is authorised in the EU
Slovenian: Pregled zdravila Kymriah in zakaj je odobreno v EU
English: Side effects reported with Kymriah are carefully evaluated and any necessary action taken to protect patients.
Slovenian: Neželeni učinki, o katerih so poročali pri zdravilu Kymriah, se skrbno ovrednotijo in po potrebi se sprejmejo ukrepi za zaščito bolnikov.
English: Twelve months after treatment, the likelihood of survival was 70%.
Slovenian: Dvanajst mesecev po zdravljenju je bila verjetnost za preživetje 70-odstotna.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Kymriah have also been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo za varno in učinkovito uporabo zdravila Kymriah upoštevati zdravstveni delavci in bolniki, so vključeni tudi v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: Twelve months after treatment, the likelihood of survival was 40%.
Slovenian: Dvanajst mesecev po zdravljenju je bila verjetnost za preživetje 40-odstotna.
English: Around 24% of patients had a complete response and 34% had at least a partial response after at least 3 months.
Slovenian: Po vsaj treh mesecih je do popolnega odziva prišlo pri približno 24 % bolnikov, do vsaj delnega odziva pa pri 34 % bolnikov.
English: For more information about using Kymriah, see the package leaflet or contact your doctor or pharmacist.
Slovenian: Za več informacij glede uporabe zdravila Kymriah glejte navodilo za uporabo ali se posvetujte z zdravnikom ali farmacevtom.
English: Around 66% of patients had a complete response (which means they had no signs of the cancer left) in the 3 months after treatment.
Slovenian: Pri približno 66 odstotkih bolnikov je v treh mesecih po zdravljenju prišlo do popolnega odziva (kar pomeni, da niso več imeli znakov raka).
English: The most common serious side effects are cytokine release syndrome (a potentially life-threatening condition that can cause fever, vomiting, shortness of breath, pain and low blood pressure) and decreases in platelets (components that help the blood to clot), haemoglobin (the protein found in red blood cells that carries oxygen around the body) or white blood cells including neutrophils and lymphocytes.
Slovenian: Najpogostejši resna neželena učinka sta sindrom sproščanja citokinov (morebitno smrtno nevarno stanje, ki lahko povzroči vročino, bruhanje, kratko sapo, bolečine in nizek krvni tlak) in zmanjšanje števila trombocitov (sestavine, ki pomaga pri strjevanju krvi), ravni hemoglobina (beljakovine v rdečih krvnih celicah, ki po telesu prenaša kisik) ali belih krvnih celic, vključno z nevtrofilci in limfociti.
English: The majority of patients who responded to Kymriah continued to have a response after 19 months.
Slovenian: Pri večini bolnikov, ki so se odzvali na zdravilo Kymriah, se je odziv ohranil še 19 mesecev po zdravljenju.
English: CAR can attach to another protein on the surface of cancer cells called CD19.
Slovenian: Ta se lahko veže na drugo beljakovino na površini rakavih celic, imenovano CD19.
English: The company must provide educational materials for healthcare professionals and patients about possible side effects, especially cytokine release syndrome.
Slovenian: Podjetje mora zagotoviti izobraževalno gradivo za zdravstvene delavce in bolnike o možnih neželenih učinkih, zlasti o sindromu sproščanja citokinov.
English: The company must carry out several studies to obtain more information on Kymriah including its safety and effectiveness in the long term and in B-cell ALL patients under 3 years of age.
Slovenian: Izvesti mora več študij, da bi pridobilo dodatne informacij o zdravilu Kymriah, vključno z njegovo dolgoročno varnostjo in učinkovitostjo ter varnostjo in učinkovitostjo pri bolnikih z B-celično akutno limfoblastno levkemijo, mlajših od treh let.
English: In patients with DLBCL treated with Kymriah, the results were similar to other treatments but ongoing study data indicate that the effects last longer.
Slovenian: Pri bolnikih z difuznim velikoceličnim B-limfomom, ki so bili zdravljeni z zdravilom Kymriah, so bili izidi podobni kot pri drugih vrstah zdravljenja, podatki iz študije, ki še poteka, pa kažejo, da bi lahko učinki trajali dalj.
English: This was better than results seen with the cancer medicines clofarabine, blinatumomab or a combination of clofarabine, cyclophosphamide and etoposide.
Slovenian: Ta izid je presegel izid zdravljenja z zdraviloma proti raku klofarabinom in blinatumomabom ali kombinacijo klofarabina, ciklofosfamida in etopozida.
English: The company that markets Kymriah must ensure that hospitals where Kymriah is given have appropriate expertise, facilities and training.
Slovenian: Podjetje, ki trži zdravilo Kymriah, mora zagotoviti, da je v bolnišnicah, v katerih se daje to zdravilo, na voljo ustrezna oprema ter ima osebje ustrezno strokovno znanje in izkušnje in je ustrezno usposobljeno.
English: When Kymriah is given to the patient, the modified T cells attach to and kill the cancer cells, thereby helping to clear the cancer from the body.
Slovenian: Po dajanju zdravila Kymriah bolniku se spremenjene celice T pritrdijo na rakave celice in jih uničijo, s tem pa pripomorejo k odstranjevanju raka iz telesa.
English: Kymriah contains the patient's own T cells (a type of white blood cell) that have been modified genetically in the laboratory so that they make a protein called chimeric antigen receptor (CAR).
Slovenian: Zdravilo Kymriah vsebuje bolnikove lastne celice T (vrsto belih krvnih celic), ki so bile v laboratoriju gensko spremenjene tako, da tvorijo beljakovino, imenovano himerni antigenski receptor (CAR).
English: A medicine called tocilizumab and emergency equipment must be available in case the patient has a potentially serious side effect called cytokine release syndrome (see risks section below).
Slovenian: Na voljo morata biti zdravilo tocilizumab in oprema za nujno medicinsko pomoč za primer, da bi se pri bolniku pojavil resen neželeni učinek, imenovan sindrom sproščanja citokinov (glejte poglavje o tveganjih v nadaljevanju).